We work with valued partners around the globe – from distributors to clinicians, developers to researchers.
While our headquarters are in London, the Allmed family is both international and local. Our global management team run our worldwide operations with invaluable local knowledge and key contacts.
We have four manufacturing sites across the EMEA region – with two sites in Germany and one apiece in Portugal and Egypt. These sites, each operating in its own area of specialisation, combine to create a real competitive point of difference, manufacturing our products more effectively and distributing them more efficiently, via our network that spans the UK, Germany, Poland, Turkey, Brazil, Egypt and India.
And our onward connections to global markets gets our products to where they’re needed, fast. Teamwork is key. That’s why we’re so proud of our trustworthy network of distributors across over 40 countries. At Allmed, we believe we work stronger when we work together.
The demands of our customers drive everything we do. From our unwavering commitment to ongoing training and quality assurance, to our adherence to the highest international standards in compliance with our multi-certified Total Quality Management System.
Allmed Group Total Quality Management Policy
Our Values: Professionalism, Integrity, Partnership, Trust & Care
Allmed Group’s goal is to meet our customers’ expectations and to be their preferred supplier for Medical Device Solutions.
Allmed employees are expected to focus at all times, on developing, manufacturing, selling and delivering innovative, safe and efficient products and services which set the benchmark for dialysis consumables.
We are committed to be in compliance with global regulatory requirements and to maintain the effectiveness of the Quality Management System.
We will ensure the effectiveness of our activities and our business with clear objectives and meaningful metrics (Key Performance Indicators which will be tailored for each plant), and our efforts will be dedicated to continuously improving out business and the quality of our Processes, Products and Services.
Allmed Group’s objectives are:
a) Implementation of the ISO 13485:2016 in all plants;
b) Implementation of 9001:2015 and ISO 14001:2016 in plants that have the previous version;
c) Improvement of the Post Market Surveillance programme;
d) Implementation of the new MEDDEV 2.7/1 Rev. 4;
e) Implementation of the new MDR (EU) 2017/745;
f) Implementation of the MDSAP regulation to replace CMDCAS, FDA, ANVISA, and TGA regulations.
This is communicated and understood within the organisation and is reviewed for continuing suitability during any Management Review.
We will ensure the management of our Processes and Products to prevent environmental pollution with adequate and safe work areas with full regard to optimal use of resources.